Ibáñez L, Potau N, Francois I, de Zegher F
Adolescent and Endocrine Unit, Hospital Universitari Materno-Infantil Vall d'Hebron, Barcelona, Spain.
J Clin Endocrinol Metab. 1998 Oct;83(10):3558-62. doi: 10.1210/jcem.83.10.5205.
Pronounced adrenarche with precocious pubarche (PP) in girls has been associated with hyperinsulinism and subsequent functional ovarian hyperandrogenism (FOH). Recently, pronounced adrenarche and insulin resistance have each been related to low birth weight. We have now tested the hypothesis that the frequent concurrence of PP with pronounced adrenarche, FOH, and hyperinsulinemia in girls may be secondary to separate relationships between these conditions and low birth weight. A total of 185 girls (aged 5-18 yr) without endocrinopathy or with PP and pronounced adrenarche with or without FOH were studied; mean serum insulin (MSI) concentrations were determined after a standardized oral glucose tolerance test. Birth weight SD scores [mean (SEM)] of control girls (0.38+/-0.08; n = 83) were higher (P < 0.0001) than those of PP girls (-0.81+/-0.13; n = 102). Among postmenarcheal PP girls, birth weight SD scores of girls without FOH (-0.25+/-0.19; n = 25) were higher (P < 0.0001) than those in girls with FOH (-1.51+/-0.28; n = 23). In pubertal girls (n = 145), MSI levels correlated negatively with birth weight SD scores (r = -0.48; P < 0.05), independently of PP. MSI levels in girls with birth weight below 1 SD (93+/-9 mU/L; n = 33) were higher (P < 0.0001) than those in girls with birth weight between -1 and +1 SD (52+/-2 mU/L; n = 94), whereas glycemia profiles were comparable. Integration of the aforementioned data suggests that there may be a sequence in the associations between reduced fetal growth and components of the postnatal endocrine system; minor fetal growth reduction appears to be associated with amplified adrenarche, whereas more pronounced prenatal growth restriction seem to precede FOH and hyperinsulinemia during adolescence. In conclusion, these findings corroborate the hypothesis that the frequent concurrence of PP (with pronounced adrenarche), FOH, and hyperinsulinemia in girls may result from a common early origin (low birth weight serving as a marker), rather than from a direct interrelationship later in life.
女孩中明显的肾上腺初现伴性早熟阴毛早现(PP)与高胰岛素血症及随后的功能性卵巢高雄激素血症(FOH)有关。最近,明显的肾上腺初现和胰岛素抵抗均与低出生体重有关。我们现在检验了这样一个假设,即女孩中PP与明显的肾上腺初现、FOH和高胰岛素血症的频繁同时出现可能继发于这些情况与低出生体重之间的独立关系。对总共185名无内分泌病或患有PP以及伴有或不伴有FOH的明显肾上腺初现的女孩(年龄5 - 18岁)进行了研究;在标准化口服葡萄糖耐量试验后测定平均血清胰岛素(MSI)浓度。对照女孩(0.38±0.08;n = 83)的出生体重标准差分数[平均值(标准误)]高于PP女孩(-0.81±0.13;n = 102)(P < 0.0001)。在月经初潮后的PP女孩中,无FOH女孩(-0.25±0.19;n = 25)的出生体重标准差分数高于有FOH女孩(-1.51±0.28;n = 23)(P < 0.0001)。在青春期女孩(n = 145)中,MSI水平与出生体重标准差分数呈负相关(r = -0.48;P < 0.05),与PP无关。出生体重低于1个标准差的女孩的MSI水平(93±9 mU/L;n = 33)高于出生体重在-1至+1个标准差之间的女孩(52±2 mU/L;n = 94)(P < 0.0001),而血糖曲线具有可比性。上述数据的整合表明,胎儿生长受限与出生后内分泌系统各组成部分之间的关联可能存在一个顺序;轻微的胎儿生长受限似乎与增强的肾上腺初现有关,而更明显的产前生长受限似乎在青春期先于FOH和高胰岛素血症出现。总之,这些发现证实了这样一个假设,即女孩中PP(伴有明显的肾上腺初现)、FOH和高胰岛素血症的频繁同时出现可能源于一个共同的早期起源(低出生体重作为一个标志),而不是源于生命后期的直接相互关系。